Boehringer Ingelheim appoints new Regional Managing Director

Mohammed Tawil will lead the company's operations from its regional headquarters in Dubai, United Arab Emirates.


United Arab Emirates: Boehringer Ingelheim, one of the world’s leading pharmaceutical companies, announced the appointment of Mohammed Tawil as Regional Managing Director for the Middle East, Turkey and Africa (META) region, in addition to his role as Head of Human Pharmaceuticals. Tawil will lead the company’s operations from its regional headquarters in Dubai, United Arab Emirates.

Prior to joining META, Tawil was a Regional Business Manager within the Emerging Markets region, based at the company’s headquarters in Germany. He was responsible for China, Mexico, Brazil and South America, where he successfully managed positive transformational changes across Boehringer Ingelheim’s Emerging Markets operations. Tawil was instrumental in supporting the expansion of the business in these markets, which represents 70% of the company’s Emerging Markets total business. He brings with him over two decades of experience combining strategic global insights with a deep knowledge and understanding of the Middle East and North Africa region, having held several leadership positions within the region. Before moving to Germany, Tawil was the General Manager for Boehringer Ingelheim Near East Middle East Area. 

As Regional Managing Director for Boehringer Ingelheim META, Tawil will focus on achieving growth and market leadership, while further developing innovative solutions that serve customers and patients across the Human Pharmaceuticals and Animal Health businesses.  

Commenting on his new role, Tawil said, “I’m excited about taking on this role and look forward to contributing to the sustainable development of the business in the region. I see tremendous potential to bring more value to the communities that we operate in through two main factors. First, that the company has a strong focus on bringing innovative solutions to patients in an effort to better serve their needs. And secondly, our region is highly responsive and open to partnerships that would reshape the overall healthcare landscape.”

Tawil believes in an inclusive leadership style that recognizes the benefit of a collaborative environment, which leverages the strengths of the team to deliver results and develop people further. “Knowledge sharing and effective teamwork are among the main driving forces in Boehringer Ingelheim. The greatest successes I have witnessed in my international career were a direct result of the combined efforts of an exceptional diverse group of professionals. I am keen to ensure that we apply this approach not only to deliver results, but to make a difference for the generations to come.”

© Press Release 2020

Disclaimer: The contents of this press release was provided from an external third party provider. This website is not responsible for, and does not control, such external content. This content is provided on an “as is” and “as available” basis and has not been edited in any way. Neither this website nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this press release.

The press release is provided for informational purposes only. The content does not provide tax, legal or investment advice or opinion regarding the suitability, value or profitability of any particular security, portfolio or investment strategy. Neither this website nor our affiliates shall be liable for any errors or inaccuracies in the content, or for any actions taken by you in reliance thereon. You expressly agree that your use of the information within this article is at your sole risk.

To the fullest extent permitted by applicable law, this website, its parent company, its subsidiaries, its affiliates and the respective shareholders, directors, officers, employees, agents, advertisers, content providers and licensors will not be liable (jointly or severally) to you for any direct, indirect, consequential, special, incidental, punitive or exemplary damages, including without limitation, lost profits, lost savings and lost revenues, whether in negligence, tort, contract or any other theory of liability, even if the parties have been advised of the possibility or could have foreseen any such damages.

More From Press Releases